Therapeutaix

TherapeutAix - R&D consulting with a difference - for investors, biotech and pharma TherapeutAix combines extensive, hands-on expertise with an integrated R&D network to add value to a project. For Investors: We help you make data-driven investment decisions on programs and assets and identify strategies to deliver early value. For Project Teams: We work collaboratively to maximize the attractiveness of your data package to a potential investor or partner. We offer: • Review/analysis of pre-IND to early clinical programs • Identification of scientific, clinical and commercial challenges and gaps • Clear progression plans and decision points to clinical PoC • Project management and delivery of decision-making studies Assessment: • Due Diligence of new opportunities; review of existing programs • Rapid, cost-effective assessment of project data and plans at all stages from project start through to clinical PoC. Strategy: • Define and build a future-proof platform of evidence to meet investor, partner and regulator expectations. • Maximise the impact of positive data. • Where uncertainty exists, we establish realistic mitigations, by identifying what to do and what not to do. Operations: • Collaborative delivery of decision-making data and information via our R&D network The TherapeutAix directors have an extensive R&D Network within the European Innovation community, and collective experience in projects in inflammation, immunology, pain, cardiovascular, and respiratory, covering both small molecules and biologics. We specialise in fibrotic disease, inflammation, and orphan / niche indications.